Marker-free genomic editing in Saccharomyces cerevisiae using universal donor templates and multiplexing CRISPR-CAS9

被引:1
作者
Grissom, J. H. [1 ]
Moody, S. E. [1 ]
Chi, R. J. [1 ]
机构
[1] Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA
基金
美国国家科学基金会;
关键词
CRISPR-Cas9; genome editing; Longtine; selectable marker; RETROGRADE TRAFFICKING; EXPERIMENTAL ORGANISM; GENE DELETION; YEAST; VERSATILE; EFFICIENT; PROTEINS; MODULES; CELLS; SNC1;
D O I
10.1002/yea.3977
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The budding yeast Saccharomyces cerevisiae is an excellent model organism for studying a variety of critical cellular processes. Traditional methods to knock in or -out at specific yeast loci utilize polymerase chain reaction-based techniques, in which marker cassettes with gene-specific homologies are integrated into the genome via homologous recombination. While simple and cost-effective, these methods are limited by marker availability when multiple edits are desired. More recently, CRISPR-Cas9 technology has introduced methods to edit the yeast genome without the need for selectable markers. Although efficient, this method is hindered by additional reagents and lengthy protocols to design and test unique guide RNAs and donor templates for each desired edit. In this study, we have combined these two approaches and have developed a highly efficient economical method to edit the yeast genome marker-free. We have designed two universal donor templates that efficiently repair commonly used selectable markers when targeted by a novel guideRNA-Cas9 designed to promoter regions in Ashbya gossypii found in most integration modules. Furthermore, we find our newly designed guideRNA-Cas9 successfully multiplexes when multiple markers are present. Using these new tools, we have significantly improved the cost and efficiency to generate single or multiple marker-free genetic modifications. In this study, we demonstrate the effectiveness of these new tools by marker-free ablating PRC1, PEP4, and PRB1 vacuolar proteases typically inactivated before many biochemical and membrane-trafficking studies using budding yeast.
引用
收藏
页码:568 / 579
页数:12
相关论文
共 50 条
  • [41] Genome editing in Shiraia bambusicola using CRISPR-Cas9 system
    Deng, Huaxiang
    Gao, Ruijie
    Liao, Xiangru
    Cai, Yujie
    JOURNAL OF BIOTECHNOLOGY, 2017, 259 : 228 - 234
  • [42] Decorating chromatin for enhanced genome editing using CRISPR-Cas9
    Chen, Evelyn
    Lin-Shiao, Enrique
    Trinidad, Marena
    Doost, Mohammad Saffari
    Colognori, David
    Doudna, Jennifer A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (49)
  • [43] Base Editing of Somatic Cells Using CRISPR-Cas9 in Drosophila
    Marr, Elizabeth
    Potter, Christopher J.
    CRISPR JOURNAL, 2021, 4 (06): : 836 - 845
  • [44] In vitro Generation of CRISPR-Cas9 Complexes with Covalently Bound Repair Templates for Genome Editing in Mammalian Cells
    Savic, Natasa
    Ringnalda, Femke C. A. S.
    Berke, Christian
    Bargsten, Katja
    Hall, Jonathan
    Jinek, Martin
    Schwank, Gerald
    BIO-PROTOCOL, 2019, 9 (01):
  • [45] PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing
    Malina, Abba
    Cameron, Christopher J. F.
    Robert, Francis
    Blanchette, Mathieu
    Dostie, Josee
    Pelletier, Jerry
    NATURE COMMUNICATIONS, 2015, 6
  • [46] Efficient intracellular delivery of CRISPR-Cas9 ribonucleoproteins using dendrimer nanoparticles for robust genomic editing
    Liyanage, Wathsala
    Kannan, Gokul R.
    Kannan, Sujatha
    Kannan, Rangaramanujam M.
    NANO TODAY, 2025, 61
  • [47] Metabolic engineering of Escherichia coli using CRISPR-Cas9 meditated genome editing
    Li, Yifan
    Lin, Zhenquan
    Huang, Can
    Zhang, Yan
    Wang, Zhiwen
    Tang, Ya-Jie
    Chen, Tao
    Zhao, Xueming
    METABOLIC ENGINEERING, 2015, 31 : 13 - 21
  • [48] Editing of Genomic TNFSF9 by CRISPR-Cas9 Can Be Followed by Re-Editing of Its Transcript
    Lee, Hyeon-Woo
    MOLECULES AND CELLS, 2018, 41 (10) : 917 - 922
  • [49] CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
    Rosenblum, Daniel
    Gutkin, Anna
    Kedmi, Ranit
    Ramishetti, Srinivas
    Veiga, Nuphar
    Jacobi, Ashley M.
    Schubert, Mollie S.
    Friedmann-Morvinski, Dinorah
    Cohen, Zvi R.
    Behlke, Mark A.
    Lieberman, Judy
    Peer, Dan
    SCIENCE ADVANCES, 2020, 6 (47)
  • [50] Droplets for Gene Editing Using CRISPR-Cas9 and Clonal Selection Improvement Using Hydrogels
    Perez-Sosa, Camilo
    Perez, Maximiliano S.
    Vallejo-Janeta, Alexander Paolo
    Bhansali, Shekhar
    Miriuka, Santiago
    Lerner, Betiana
    MICROMACHINES, 2024, 15 (03)